Simulation Study Design and Methodology for Evaluating Time-to-Onset Estimation in Right-Truncated Data
To assess the performance of parametric maximum likelihood estimation (MLE) under right truncation, a comprehensive simulation study was conducted across three parametric distributions: exponential, Weibull, and log-logistic. These distributions were selected due to their flexibility in modeling various hazard functions commonly encountered in pharmacovigilance, including constant, increasing, decreasing, and bathtub-shaped risks. The exponential distribution serves as a baseline with constant hazard, while the Weibull and log-logistic models allow for time-dependent risk patterns through their shape parameters.
Twelve distinct scenarios were defined for the exponential distribution, varying the rate parameter λ (0.05, 1). For both the Weibull and log-logistic families, two values of the scale parameter β (0.05, 1) and two values of the shape parameter γ (0.5, 2) were considered, resulting in 24 scenarios per distribution. The probability p that the true time-to-onset falls within the observable interval [0, t̄] was set at 0.25, 0.50, and 0.80, representing low, moderate, and high observability conditions. The truncation time t̄ was determined such that P(X < t̄) = p, ensuring controlled levels of truncation. For each scenario, survival times X were independently generated from the specified distribution, and corresponding truncation times T were drawn from a uniform distribution over [0, t̄]. Only pairs where X ≤ T were retained, simulating real-world reporting constraints. Sample sizes of n = 100 and n = 500 were used to evaluate performance across typical data volumes found in spontaneous reporting systems. A total of 1,000 replications were performed per scenario to ensure robust estimation of bias, mean squared error (MSE), and proportion of overestimation. Two estimation approaches were compared: the naive approach, which ignores truncation and uses standard MLE on observed (X_i, T_i) pairs; and the truncation-based estimator (TBE), which accounts for right truncation by maximizing the conditional likelihood L₂ = ∏[f(x_i; θ)/F(t_i; θ)].Cadherin-17 ProteinBiological Activity The latter requires iterative optimization via the maxLik package in R, with convergence monitored throughout.
Bias was calculated as the average difference between estimated and true parameter values across replications, while MSE combined variance and squared bias. The proportion of replications where the estimate exceeded the true value was also recorded to assess systematic overestimation tendencies. All metrics were computed only on converged runs, excluding cases where the iterative algorithm failed to locate a maximum—particularly common under heavy truncation (low p).N-(4-Bromphenyl)-3-phenylpropanamid manufacturer
Results demonstrated consistent superiority of the TBE across all distributions and conditions.PMID:35161856 Bias and MSE remained stable or decreased with increasing sample size under TBE, whereas the naive estimator showed persistent, large biases regardless of n. Notably, even when p = 0.80, the naive method produced unacceptably high errors in some cases, especially for Weibull and log-logistic models. In contrast, TBE maintained satisfactory accuracy, particularly when p ≥ 0.80. The number of maximization failures increased with lower p, indicating computational challenges but not invalidating the overall conclusions.
These simulations provide strong empirical evidence that ignoring right truncation leads to unreliable estimates, while proper statistical methods yield valid, efficient inference. The design ensures broad applicability to real-world pharmacovigilance datasets, offering a benchmark for future methodological development.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com
The human EGF repeat-specific O-GlcNAc transferase EOGT is a conserved enzyme responsible for modifying epidermal growth factor (EGF) repeats in secreted glycoproteins. In this study, we demonstrate that a splice variant of the human C3orf64 gene, cloned from HEK 293T cells (GenBank accession KC347596.1), encodes a fully functional homologue of Drosophila Eogt. This protein was tested in S2 cells using a soluble fragment of Drosophila Notch tagged with alkaline phosphatase (N(EGF1-20)-AP), which contains multiple consensus sites for Eogt modification. Co-transfection with human EOGT cDNA resulted in robust O-GlcNAcylation of N(EGF1-20)-AP, as detected by anti-O-GlcNAc antibody CTD110.6. In contrast, co-expression of mouse Ago61—a related glycosyltransferase—failed to generate any detectable O-GlcNAc signal, confirming the specificity of human EOGT activity.
A key feature of metal-dependent glycosyltransferases is the presence of a DXD motif involved in coordinating divalent cations essential for nucleotide sugar donor binding. Human EOGT contains a putative DYD motif, which is highly conserved across vertebrates. To assess its functional importance, we generated a mutant form where DYD was replaced with AYA, thereby eliminating the side chains predicted to bind bivalent cations. When expressed in S2 cells treated with eogt dsRNA, the mutant EOGT(AYA) showed significantly reduced O-GlcNAc transfer activity compared to wild-type EOGT(DYD), despite being expressed at higher levels. This reduction in function indicates that the DXD motif is critical for optimal catalytic efficiency, although not absolutely required, as residual activity was still detectable.Inclisiran web This finding aligns with prior observations that Drosophila Eogt retains low-level activity even in the absence of divalent cations.Losartan GPCR/G Protein
We further investigated whether Eogt modifies other EGF-containing proteins beyond Notch.PMID:35033844 The Notch ligands Delta and Serrate were analyzed due to their structural similarity and known roles in developmental signaling. Both proteins contain multiple perfect matches to the Eogt consensus sequence (C5XXGXT/SGXXC6). In S2 cells, endogenous Eogt efficiently modified Delta, while Ser remained largely unmodified. However, co-expression of human EOGT led to clear O-GlcNAcylation of Ser, demonstrating that it can serve as a substrate when Eogt is overexpressed. These results confirm that Eogt has broad specificity for EGF repeats in both ligands and receptors, extending its regulatory role beyond Notch itself.
This work establishes human EOGT as a functional orthologue capable of restoring O-GlcNAc modification in Drosophila systems. Its dependence on a conserved DXD motif underscores the evolutionary conservation of catalytic mechanisms among EGF-specific O-GlcNAc transferases. The ability of human EOGT to rescue Drosophila eogt mutants in vivo further supports its biological relevance and potential utility in modeling human glycosylation disorders. Together, these findings provide strong evidence that EOGT functions through a defined molecular mechanism involving specific recognition of EGF repeats and requires a functional DXD motif for full enzymatic activity. This insight enhances our understanding of how O-GlcNAc modifications regulate protein structure and function in development and disease.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com
Achillea millefolium L., commonly known as yarrow, is a perennial herb belonging to the Asteraceae family that has been widely used in traditional medicine across Europe, Asia, and North America. Its therapeutic applications include treating inflammatory conditions, gastrointestinal disorders, and wound healing. The plant’s bioactive properties are attributed to its rich phytochemical composition, particularly its essential oil (AM-EO), which contains various terpenoids and phenolic compounds. In this study, gas chromatography-mass spectrometry (GC-MS) analysis identified 19 compounds in AM-EO, with artemisia ketone (14.92%), camphor (11.64%), linalyl acetate (11.51%), and 1,8-cineole (10.15%) as the major constituents. These components are known for their antioxidant, anti-inflammatory, and antimicrobial activities.
To evaluate the biological effects of AM-EO, RAW 264.7 murine macrophage cells were stimulated with lipopolysaccharides (LPS) to induce an inflammatory response. AM-EO treatment at concentrations ranging from 20 to 80 µg/mL did not affect cell viability, indicating no cytotoxicity. However, it significantly reduced nitric oxide (NO) production in a dose-dependent manner, with an approximate 35% inhibition observed at 80 µg/mL. This suggests that AM-EO can modulate the overproduction of NO, a key mediator in inflammation.
Further investigation revealed that AM-EO effectively suppressed oxidative stress markers in LPS-stimulated macrophages. Superoxide anion levels decreased by 58% at 20 µg/mL, and lipid peroxidation, measured by malondialdehyde (MDA) formation, was also markedly reduced. Additionally, intracellular glutathione (GSH) levels, a crucial endogenous antioxidant, were preserved, indicating enhanced cellular redox balance.Mebendazole supplier DNA fragmentation assays showed diminished DNA laddering in AM-EO-treated cells, suggesting protection against LPS-induced apoptosis.
Interestingly, while antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) were downregulated in a dose-dependent fashion, their activity was not increased by AM-EO. This implies that the antioxidant effect is not mediated through upregulation of enzymatic defenses but rather through direct scavenging or modulation of inflammatory pathways.beta Amyloid 1-40 Antibody In stock
The anti-inflammatory mechanism of AM-EO was further elucidated by examining the expression of key inflammatory genes.PMID:35073772 Reverse transcription PCR demonstrated significant downregulation of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and heme oxygenase-1 (HO-1). Notably, IL-6 mRNA expression was reduced by approximately 50% at 80 µg/mL, highlighting potent suppression of pro-inflammatory signaling. The reduction in HO-1 expression supports the idea that AM-EO attenuates inflammation primarily via antioxidant actions rather than activation of protective stress-response pathways.
These findings collectively indicate that Achillea millefolium essential oil exerts strong anti-inflammatory and antioxidant effects in LPS-stimulated RAW 264.7 macrophages. The primary mechanisms involve inhibition of iNOS, COX-2, TNF-α, and IL-6 expression, along with direct suppression of oxidative stress without reliance on enhanced antioxidant enzyme activity. Given these results, AM-EO holds significant potential as a natural therapeutic agent for managing chronic inflammatory diseases, including those associated with oxidative damage. Future studies should focus on in vivo validation and clinical applications, particularly in dietary supplements, functional foods, and topical formulations.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com
Innate immune responses are critical for the initial defense against influenza A virus (IAV) infection. However, an exaggerated cytokine response, often termed a “cytokine storm,” contributes significantly to disease severity and mortality. Among the key mediators of this response are interferon lambda (IFN-l), which play pivotal roles in antiviral defense, particularly in epithelial cells lining the respiratory tract. Despite their importance, the mechanisms governing IFN-l overproduction during IAV infection remain poorly understood. This study reveals that IAV infection induces robust expression of IFN-l primarily through a RIG-I-dependent pathway in alveolar epithelial cells (A549). Yet, paradoxically, signaling downstream of IFN-l—specifically phosphorylation of STAT1—is severely inhibited in infected cells. This suppression is driven by the upregulation of suppressor of cytokine signaling-1 (SOCS-1), a potent negative regulator of JAK-STAT signaling. Notably, SOCS-1 induction occurs early during infection and is independent of cytokine feedback loops, both in vitro and in vivo. Using transgenic mouse models and genetic interventions, we demonstrate that disrupting SOCS-1 expression or expressing a constitutively active form of STAT1 significantly reduces IFN-l production. Furthermore, we uncover a compensatory mechanism: inhibition of IFN-l signaling leads to activation of NF-kB, which in turn enhances IFN-l transcription. These findings suggest that viral-induced SOCS-1 triggers a maladaptive host response, where impaired IFN-l signaling results in excessive IFN-l production as a failed attempt to bolster antiviral defense. This cycle ultimately leads to immunopathology without effective viral control, highlighting SOCS-1 as a central player in the dysregulation of innate immunity during severe influenza infection.
The Role of RIG-I in Inducing IFN-l Expression during IAV Infection
To understand how IAV triggers the innate immune response, we investigated the molecular pathways leading to IFN-l expression in human alveolar epithelial A549 cells. Microarray analysis revealed significant upregulation of IFN-l family members—IL-28A, IL-28B, and IL-29—following infection with A/WSN/33 (H1N1) virus. Quantitative RT-PCR confirmed these findings in both A549 cells and mouse lung tissues, while ELISA detected elevated IL-29 protein levels in culture supernatants. Importantly, heat-inactivated virus (56°C) or denatured virus (65°C) failed to induce IFN-l, indicating that live viral replication is required for robust expression.RF9 manufacturer Transfection experiments using total RNA isolated from infected cells demonstrated that both viral genomic RNA and newly synthesized viral transcripts contribute to IFN-l induction. Critically, removal of the 5′-triphosphate group on viral RNA via calf intestine alkaline phosphatase (CIAP) drastically reduced IFN-l expression, implicating the 5′-triphosphate moiety as a key pathogen-associated molecular pattern (PAMP). To identify the sensor responsible, we used shRNA-mediated knockdown of RIG-I, TLR3, and MDA5. Silencing RIG-I led to a marked reduction in IFN-l production, whereas TLR3 knockdown had only a minor effect, and MDA5 silencing showed no impact. These results indicate that RIG-I is the dominant sensor for initiating IFN-l expression in response to IAV, acting through recognition of viral RNA with 5′-triphosphate ends.
Inhibition of IFN-l-Induced STAT1 Phosphorylation by Viral Infection
Despite strong induction of IFN-l, downstream signaling remains dysfunctional during IAV infection. We examined whether IFN-l could activate its canonical JAK-STAT pathway in A549 cells. Stimulation with recombinant IL-29 induced dose-dependent phosphorylation of STAT1, confirming functional receptor signaling in uninfected cells. However, in IAV-infected cells, STAT1 phosphorylation was dramatically suppressed even when exposed to exogenous IL-29. Time-course analysis showed that this inhibition became pronounced after 15 hours post-infection, coinciding with peak viral replication. Importantly, treatment with conditioned medium from infected cells did not recapitulate the suppression, ruling out soluble inhibitors released into the culture environment. Instead, the defect appears intrinsic to infected cells, suggesting that viral proteins actively interfere with the IFN-l signaling cascade. This observation implies that IAV has evolved mechanisms to block autocrine and paracrine IFN-l signaling, thereby undermining the antiviral state despite high cytokine levels.
SOCS-1 Upregulation Mediates Suppression of STAT1 Activation
Given the critical role of SOCS-1 as a negative regulator of cytokine signaling, we assessed its expression during IAV infection. Quantitative RT-PCR showed rapid and sustained upregulation of SOCS-1 mRNA early in infection, followed by a decline at later stages. Western blotting confirmed a consistent increase in SOCS-1 protein levels throughout infection. Immunofluorescence staining localized SOCS-1 expression specifically to IAV-infected cells, with concomitant loss of STAT1 phosphorylation. Notably, supernatants from infected cultures could induce SOCS-1 expression only at later time points, indicating that SOCS-1 induction is initially triggered directly by viral infection rather than by secreted cytokines. To determine functional relevance, we used shRNA to knock down SOCS-1 in A549 cells. In SOCS-1-deficient cells, STAT1 phosphorylation was markedly enhanced upon IAV infection, demonstrating that SOCS-1 acts as a direct inhibitor of IFN-l signaling. These data establish that IAV-induced SOCS-1 is a key mediator of impaired STAT1 activation, contributing to the failure of effective antiviral signaling.
Disruption of IFN-l Signaling Leads to NF-kB Activation and Excessive IFN-l Production
We next explored how suppression of IFN-l signaling results in increased IFN-l expression. Our hypothesis was that blocking JAK-STAT signaling might relieve negative feedback and allow alternative transcription factors to drive IFN-l gene expression. Indeed, we found that forced activation of STAT1 via constitutively active STAT1-2C mutant significantly reduced IFN-l production during IAV infection. Similarly, SOCS-1 knockdown in A549 cells led to decreased IL-29 and IL-28A/B mRNA levels. Surprisingly, despite reduced IFN-l, antiviral ISG expression (e.g., OAS-2, Mx1) remained intact, suggesting that the antiviral response is preserved even when IFN-l is lower. Mechanistically, we observed that disruption of IFN-l signaling led to enhanced NF-kB activity. Luciferase reporter assays and Western blotting revealed increased NF-kB-driven transcription and degradation of IkBα, the inhibitor of NF-kB, in SOCS-1-deficient or STAT1-activated cells. Conversely, SOCS-1 overexpression enhanced NF-kB activation. Immunofluorescence confirmed nuclear translocation of p65 subunit of NF-kB in control cells but not in SOCS-1-ablated or STAT1-activated cells. These findings reveal a reciprocal relationship: suppression of IFN-l signaling by SOCS-1 unleashes NF-kB, which then drives further IFN-l expression, creating a self-amplifying loop that results in pathological overproduction.
In Vivo Validation of SOCS-1’s Role in IFN-l Overproduction
To confirm these findings in a physiological context, we conducted in vivo studies using BALB/c mice infected with IAV. SOCS-1 protein levels were consistently elevated in lung tissues during the first three days post-infection, paralleling reduced STAT1 phosphorylation.Phospho-Smad1/5/9 Antibody Cancer Concurrently, NF-kB activity increased, as evidenced by diminished IkBα levels.PMID:35067796 Interestingly, SOCS-1 expression preceded that of IFN-l, supporting the idea of a cytokine-independent induction mechanism. We administered membrane-permeable peptides mimicking SOCS-1’s kinase inhibitory region (SOCS-1-KIR) or a competitive inhibitor of JAK2 (pJAK2) to modulate signaling. Mice treated with SOCS-1-KIR exhibited significantly higher IFN-l levels, while those treated with pJAK2 showed reduced IFN-l expression. Moreover, SOCS-1-KIR treatment worsened body weight loss, whereas pJAK2 improved survival outcomes. These results confirm that SOCS-1-mediated suppression of IFN-l signaling promotes excessive IFN-l production in vivo, contributing to immunopathology.
Functional Impact of SOCS-1 Knockdown in Transgenic Mice
To further dissect the role of SOCS-1 in IFN-l regulation, we generated SOCS-1-knockdown transgenic mice using shRNA technology. These mice displayed enhanced STAT1 phosphorylation and reduced NF-kB activation upon IAV infection. Consequently, IFN-l expression was significantly lower in transgenic animals compared to wild-type controls. Histological analysis revealed attenuated lung inflammation in SOCS-1-deficient mice, and they exhibited less body weight loss and reduced viral loads. These findings indicate that dampening SOCS-1 expression improves antiviral immunity and reduces tissue damage despite lower IFN-l levels. The results underscore that excessive IFN-l production is not beneficial and may be detrimental, reinforcing the notion that SOCS-1 acts as a rheostat whose overactivity disrupts immune homeostasis.
Conclusion and Implications for Influenza Pathogenesis
This study uncovers a novel mechanism by which IAV exploits host regulatory networks to induce pathological IFN-l overproduction. By inducing SOCS-1, the virus suppresses IFN-l signaling, triggering a compensatory activation of NF-kB that drives further IFN-l synthesis. This creates a vicious cycle: more IFN-l is produced, but its signaling is blocked, resulting in ineffective antiviral responses and heightened inflammation. The imbalance between cytokine production and functional signaling underlies the immunopathology seen in severe influenza. Targeting SOCS-1 or enhancing STAT1 activity may represent promising therapeutic strategies to restore immune balance and reduce disease severity. These findings highlight the complexity of host-virus interactions and emphasize the need for therapies that go beyond simple immune stimulation to correct dysregulated signaling pathways.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com
Living organisms create carbon-sulfur bonds during biosynthesis of essential sulfur-containing compounds through complex enzymatic mechanisms. The methylthiotransferases MiaB and RimO are key enzymes in this process, catalyzing sulfur insertion into tRNAs and ribosomal protein S12, respectively. Both belong to a sub-group of Radical-SAM enzymes characterized by the presence of two [4Fe-4S] clusters. While one cluster binds S-adenosylmethionine (SAM) and generates a 5′-deoxyadenosyl radical (Ado·) via a well-established mechanism, the role of the second cluster has remained enigmatic. For some sulfur-inserting Radical-SAM enzymes, it has been proposed that this cluster acts as a sacrificial source of sulfur. However, recent parallel enzymological, spectroscopic, and crystallographic studies on RimO and MiaB provide compelling evidence that these enzymes function as true catalysts rather than sacrificial systems. Instead, the data support a novel sulfation mechanism in which an exogenous sulfur co-substrate is activated at an exchangeable coordination site on the second [4Fe-4S] cluster, which remains intact throughout the reaction cycle.
This mechanism represents a significant departure from the previously accepted “sacrificial cluster” model, particularly based on observations from biotin synthase (BioB), where sulfur is extracted from the second Fe-S cluster, leading to its partial disassembly and reconstitution in each turnover. In contrast, the current findings demonstrate that both MiaB and RimO retain their iron-sulfur clusters intact during catalysis. This conclusion is supported by multiple lines of evidence: enzymatic assays show multiple turnovers using sulfide, methylsulfide, selenide, or methylselenide as co-substrates; EPR and HYSCORE spectroscopy confirm the binding of CH₃Se⁻ to an intact cluster II without degradation; and the high-resolution crystal structure of holo TmRimO reveals a pentasulfide bridge connecting the two [4Fe-4S] clusters, indicating that excess sulfur is stored in a polysulfide moiety bound to the enzyme. Upon reduction with dithionite under assay conditions, this polysulfide is cleaved to release sulfide ions that serve as the active sulfur donor.
Structural analysis further reveals that the two clusters in RimO are only 8 Å apart, bridged by the pentasulfide chain, contrasting with the greater separation observed in other Radical-SAM enzymes such as BioB (12 Å) and MoaA (16 Å). This close proximity facilitates efficient sulfur transfer and suggests a highly coordinated mechanism. The active site funnel, approximately 40 Å deep and lined with acidic residues, is structurally poised to bind the basic ribosomal protein S12, consistent with its physiological substrate. Moreover, the UPF0004 domain, which binds cluster II, exhibits structural similarity to signal transduction proteins like CheY and NarL, implying potential conformational changes upon substrate binding that may regulate catalytic efficiency.PRAME peptide (425-433) acetate Neuronal Signaling
These findings redefine the functional role of the second [4Fe-4S] cluster in methylthiotransferases. Rather than serving as a sacrificial sulfur reservoir, it functions as a catalytic platform for activating exogenous sulfur species. This activation likely occurs at a labile coordination site on cluster II, enabling the formation of a reactive intermediate such as a [4Fe-4S]-SCH₃ complex.L-Ascorbic acid Neuronal Signaling The subsequent cooperation between this species and the Ado· radical generated from SAM would enable the conversion of a C–H bond into a C–SCH₃ bond—a chemically challenging transformation central to the biosynthesis of thionucleosides and methylthio-amino acids.PMID:34700177
In summary, the study demonstrates that MiaB and RimO are true catalysts whose iron-sulfur clusters are preserved during catalysis. The proposed mechanism involving activation of exogenous sulfur at an accessible site on cluster II offers a new paradigm for understanding sulfur insertion reactions in biological systems. It also highlights the versatility of Radical-SAM enzymes in harnessing redox-active metal centers for diverse biochemical transformations. Future work will focus on elucidating the precise chemical steps involved in the formation of the C–S bond and determining whether differences exist in how RimO modifies sp³-hybridized carbons versus MiaB’s modification of aromatic rings.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com